Journals / Okmeydanı Tıp Dergisi / 2018 / Cilt: 34 - Sayı: 1

A case of glutaric aciduria type 1 diagnosed at an early age

Erken Yaşta Tanı Alan Bir Glutarik Asidüri Tip 1 Olgusu

Pages
46–49
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, we aimed to emphasize the importance of early diagnosis and treatment in glutaric aciduria type 1 by presenting a six-month-old male patient who was admitted to our clinic with the complaints of fever and cough and identified with macrocephaly on the physical examination and developed dyskinetic movements and convulsions on his follow-up.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Glutaric aciduria type 1 is an autosomal recessive rare neurometabolic disease caused by the deficiency of glutaryl-coenzyme A dehydrogenase which has a part in Llysine, L-hydroxylysine and L-tryptophan metabolism.
📊
Key Findings & Data:Tandem-mass spectrometry, urine organic acid analysis and brain magnetic resonance imaging can be used to diagnose glutaric aciduria type 1.
💡
Conclusion & Impact:In this article, we aimed to emphasize the importance of early diagnosis and treatment in glutaric aciduria type 1 by presenting a six-month-old male patient who was admitted to our clinic with the complaints of fever and cough and identified with macrocephaly on the physical examination and developed dyskinetic movements and convulsions on his follow-up.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Glutaric aciduria type 1 is an autosomal recessive rare neurometabolic disease caused by the deficiency of glutaryl-coenzyme A dehydrogenase which has a part in Llysine, L-hydroxylysine and L-tryptophan metabolism. It may be manifested by convulsion, dystonia and dyskinetic movements or by chronic course such as the loss of the neuromotor development stages following an infection, a routine vaccination or surgery. Majority of the patients has macrocephaly. Tandem-mass spectrometry, urine organic acid analysis and brain magnetic resonance imaging can be used to diagnose glutaric aciduria type 1. The progression of the disease may be limited considerably with lysine restricted diet and L-carnitine supplementation. In this article, we aimed to emphasize the importance of early diagnosis and treatment in glutaric aciduria type 1 by presenting a six-month-old male patient who was admitted to our clinic with the complaints of fever and cough and identified with macrocephaly on the physical examination and developed dyskinetic movements and convulsions on his follow-up.

Özet

Glutarik asidüri tip 1, L-lizin, L-hidroksilizin ve L-triptofan metabolizmasında rol alan glutaril koenzim A dehidrogenaz enzim eksikliğine bağlı olarak otozomal resesif kalıtılan ender görülen nörometabolik bir hastalıktır. Hastalık geçirilen bir enfeksiyonu, rutin aşılamayı ya da cerrahi müdahaleyi takiben başlayan konvülziyon, distoni ve diskinetik hareketlerle veya nöromotor gelişim basamaklarının kaybı gibi kronik seyirli bir tablo ile ortaya çıkabilir. Makrosefali hastaların büyük bir kısmında bulunmaktadır. Tandem-mass spektrometre, idrar organik asit analizi ve beyin manyetik rezonans görüntülemesi ile glutarik asidüri tip 1 tanısı konulabilir. Tedavide lizinden kısıtlı diyet ile L-karnitin başlanarak hastalığın ilerlemesi büyük ölçüde önlenebilir. Bu makalede, kliniğimize ateş ve öküsürük yakınması nedeniyle başvuran, fizik muayenesinde makrosefali saptanan ve izleminde diskinetik hareketleri ve konvülziyonu gözlenen altı aylık erkek hasta sunularak glutarik asidüri Tip 1'de erken tanı ve tedavinin öneminin vurgulanması amaçlanmıştır.

🔖

Cite This Article

DURAS, E., TÜRKMENOĞLU, Y., DEVELİ, B. Y., GÖZÜBÜYÜK, A. A., GÖKSOY, Ö. E. T., ÖZKAYA, O. (2018). A case of glutaric aciduria type 1 diagnosed at an early age. Okmeydanı Tıp Dergisi, Cilt: 34 - Sayı: 1, 46–49. https://ajindex.com/articles/291632

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Hoffmann GF, Athanassopoulos S, Burlina AB, et al. Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency. Neuropediatrics. 1996;27(3):115-23.
  2. Kliegman, Robert, Richard E. Behrman, and Waldo E. Nelson. Nelson textbook of pediatrics. 20th edition. Elsevier Health Sciences. 2016, 676
  3. Kölker S, Garbade SF, Greenberg CR, et al. Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res. 2006;59(6):840-7.
  4. Pfeil J, Listl S, Hoffmann GF, et al. Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis. Orphanet J Rare Dis. 2013;17;8:(167):1-11
  5. Bjugstad KB, Goodman SI, Freed CR. Age at symptom onset predicts severity of motor impairment and clinical outcome of glutaric acidemia tip 1. J Pediatr. 2000;137:681-6.
  6. Harting I, Neumaier-Probst E, Seitz A, et al. Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I. Brain. 2009;132(Pt 7):1764-82.
  7. Yüksel D, Şahin M, Yavuz Gürer YK. İki taraflı temporal araknoid kistler ve glütarik asidüri tip 1. Türk Ped Arş. 2008;43:102-4
  8. Kolker S, Ahlemeyer B, Krieglstein J, Hoffmann GF. Maturation-dependent neurotoxicity of 3-hydroxy glutaric and glutaric acids in vitro: a new pathophysiologic approach to glutaryl-CoA-dehydrogenase deficiency. Pediatr Res. 2000;47:495-503.
  9. Sarar M, Hamad MH, Hassan HH, Salih MA. Glutaric aciduria type 1 as a cause of dystonic cerebral palsy. Saudi Med J. 2015;36(11):1354-57.
  10. Kiykim E, Zeybek CA, Zubarioglu T, et al. Inherited metabolic disorders in Turkish patients with autism spectrum disorders. Autism Res. 2016;9(2):217-23.
  11. Lindner M, Kolkers S, Schulze A, et al. Neonatal screening for glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 2004;27:851-9. https://doi.org/10.1023/B:BOLI.0000045769.96657.af